UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 47

Sortiert nach

Efficacy of Agomelatine in Generalized Anxiety Disorder : A Randomized, Double-Blind, Placebo-Controlled Study

Journal of clinical psychopharmacology, 2008-10, Vol.28 (5), p.561-566

2008

Volltextzugriff (PDF)

Venlafaxine extended-release capsules in panic disorder: Flexible-dose, double-blind, placebo-controlled study

British journal of psychiatry, 2005-10, Vol.187 (4), p.352-359

2005

Volltextzugriff (PDF)

The efficacy of agomelatine in elderly patients with recurrent major depressive disorder: a placebo-controlled study

The journal of clinical psychiatry, 2013-06, Vol.74 (6), p.587

2013

Volltextzugriff (PDF)

Agomelatine prevents relapse in generalized anxiety disorder: a 6-month randomized, double-blind, placebo-controlled discontinuation study

The journal of clinical psychiatry, 2012-07, Vol.73 (7), p.1002

2012

Volltextzugriff (PDF)

Extended-release quetiapine fumarate (quetiapine XR): a once-daily monotherapy effective in generalized anxiety disorder. Data from a randomized, double-blind, placebo- and active-controlled study

The international journal of neuropsychopharmacology, 2010-04, Vol.13 (3), p.305-320

2010

Volltextzugriff (PDF)

Accumulation of Macrophages in the CSF of Schizophrenic Patients During Acute Psychotic Episodes

The American journal of psychiatry, 1999-11, Vol.156 (11), p.1725-1729

1999

Volltextzugriff (PDF)

Effect of agomelatine 25–50 mg on functional outcomes in patients with major depressive disorder

Journal of affective disorders, 2018-10, Vol.238, p.122-128

2018

Volltextzugriff (PDF)

Allopregnanolone and progesterone in estradiol treated severe postpartum affective disorder

PSYCHONEUROENDOCRINOLOGY, 2019-09, Vol.107, p.68-68

2019

Volltextzugriff (PDF)

Agomelatine in generalized anxiety disorder: an active comparator and placebo-controlled study

The journal of clinical psychiatry, 2014-04, Vol.75 (4), p.362

2014

Volltextzugriff (PDF)

Efficacy and safety of agomelatine (10 or 25 mg/day) in non-depressed out-patients with generalized anxiety disorder: A 12-week, double-blind, placebo-controlled study

European neuropsychopharmacology, 2017-05, Vol.27 (5), p.526-537

2017

Volltextzugriff (PDF)

12-week double-blind randomized multicenter study of efficacy and safety of agomelatine (25–50 mg/day) versus escitalopram (10–20 mg/day) in out-patients with severe generalized anxiety disorder

European neuropsychopharmacology, 2018-08, Vol.28 (8), p.970-979

2018

Volltextzugriff (PDF)

Sublingual oestrogen treatment of postnatal depression

The Lancet (British edition), 1998-01, Vol.351 (9096), p.109-109

1998

Volltextzugriff (PDF)

Allopregnanolone and progesterone in estradiol treated severe postpartum depression and psychosis – Preliminary findings

Neurology, psychiatry, and brain research, 2019-12, Vol.34, p.50-57

2019

Volltextzugriff (PDF)

Dropout rates in randomised antipsychotic drug trials

Psychopharmacologia, 2001-05, Vol.155 (3), p.230-233

2001

Volltextzugriff (PDF)

A placebo-controlled study of three agomelatine dose regimens (10 mg, 25 mg, 25–50 mg) in patients with major depressive disorder

European neuropsychopharmacology, 2014-04, Vol.24 (4), p.553-563

2014

Volltextzugriff (PDF)

Positive treatment effect of estradiol in postpartum psychosis: a pilot study

The journal of clinical psychiatry, 2000-03, Vol.61 (3), p.166

2000

Volltextzugriff (PDF)

The DSM-IV-Based Generalized Anxiety Disorder Severity Scale: Preliminary Validation Using Data From a Trial of Agomelatine Versus Placebo

The journal of nervous and mental disease, 2009-06, Vol.197 (6), p.391-394

2009

Volltextzugriff (PDF)

Effect of oestradiol on postpartum depression

Psychopharmacologia, 1999-09, Vol.146 (1), p.108-110

1999

Volltextzugriff (PDF)

The DSM-IV-Based Generalized Anxiety Disorder Severity Scale: Preliminary Validation Usinq Data From a Trial of Aqomelatine Versus Placebo

The journal of nervous and mental disease, 2009, Vol.197 (6), p.391-394

2009

Volltextzugriff (PDF)

Role of estradiol in puerperal psychosis

Psychopharmacologia, 1999-11, Vol.147 (1), p.108-110

1999

Volltextzugriff (PDF)

Circadian rhythm of white blood cells during clozapine treatment

Psychopharmacologia, 1999-06, Vol.144 (3), p.301-302

1999

Volltextzugriff (PDF)

Increased frequency of activated lymphocytes in the cerebrospinal fluid of patients with acute schizophrenia

Schizophrenia research, 2001-04, Vol.49 (1), p.99-105

2001

Volltextzugriff (PDF)

Risperidone versus clozapine in treatment-resistant schizophrenia: A randomized pilot study

Progress in neuro-psychopharmacology & biological psychiatry, 2000-08, Vol.24 (6), p.911-922

2000

Volltextzugriff (PDF)

Venlafaxine extended-release capsules in panic disorder

British journal of psychiatry, 2005-10, Vol.187 (4), p.352-359

2005

Volltextzugriff (PDF)

Deramciclane in the treatment of generalized anxiety disorder: A placebo-controlled, double-blind, dose-finding study

European neuropsychopharmacology, 2005-12, Vol.15 (6), p.617-623

2005

Volltextzugriff (PDF)

1 – 25 von 47

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(40)
Mit Volltextzugriff
(40)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(29)
Life Sciences & Biomedicine
(29)
Science & Technology
(29)
Psychiatry
(28)
Adult
(25)
Female
(24)
Male
(22)
Biological And Medical Sciences
(21)
Medical Sciences
(21)
Psychology. Psychoanalysis. Psychiatry
(19)
Middle Aged
(17)
Neurosciences & Neurology
(13)
Pharmacology. Drug Treatments
(12)
Psychopathology. Psychiatry
(12)
Neurosciences
(11)
Pharmacology & Pharmacy
(11)
Schizophrenia
(11)
Adolescent
(10)
Adult And Adolescent Clinical Studies
(10)
Aged
(10)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Efficacy of Agomelatine in Generalized Anxiety Disorder : A Randomized, Double-Blind, Placebo-Controlled Study

Venlafaxine extended-release capsules in panic disorder: Flexible-dose, double-blind, placebo-controlled study

The efficacy of agomelatine in elderly patients with recurrent major depressive disorder: a placebo-controlled study

Agomelatine prevents relapse in generalized anxiety disorder: a 6-month randomized, double-blind, placebo-controlled discontinuation study

Extended-release quetiapine fumarate (quetiapine XR): a once-daily monotherapy effective in generalized anxiety disorder. Data from a randomized, double-blind, placebo- and active-controlled study

Accumulation of Macrophages in the CSF of Schizophrenic Patients During Acute Psychotic Episodes

Effect of agomelatine 25–50 mg on functional outcomes in patients with major depressive disorder

Allopregnanolone and progesterone in estradiol treated severe postpartum affective disorder

Agomelatine in generalized anxiety disorder: an active comparator and placebo-controlled study

Efficacy and safety of agomelatine (10 or 25 mg/day) in non-depressed out-patients with generalized anxiety disorder: A 12-week, double-blind, placebo-controlled study

12-week double-blind randomized multicenter study of efficacy and safety of agomelatine (25–50 mg/day) versus escitalopram (10–20 mg/day) in out-patients with severe generalized anxiety disorder

Sublingual oestrogen treatment of postnatal depression

Allopregnanolone and progesterone in estradiol treated severe postpartum depression and psychosis – Preliminary findings

Dropout rates in randomised antipsychotic drug trials

A placebo-controlled study of three agomelatine dose regimens (10 mg, 25 mg, 25–50 mg) in patients with major depressive disorder

Positive treatment effect of estradiol in postpartum psychosis: a pilot study

The DSM-IV-Based Generalized Anxiety Disorder Severity Scale: Preliminary Validation Using Data From a Trial of Agomelatine Versus Placebo

Effect of oestradiol on postpartum depression

The DSM-IV-Based Generalized Anxiety Disorder Severity Scale: Preliminary Validation Usinq Data From a Trial of Aqomelatine Versus Placebo

Role of estradiol in puerperal psychosis

Circadian rhythm of white blood cells during clozapine treatment

Increased frequency of activated lymphocytes in the cerebrospinal fluid of patients with acute schizophrenia

Risperidone versus clozapine in treatment-resistant schizophrenia: A randomized pilot study

Venlafaxine extended-release capsules in panic disorder

Deramciclane in the treatment of generalized anxiety disorder: A placebo-controlled, double-blind, dose-finding study

Suchergebnisse filtern